Alexion Pharmaceuticals Inc (ALXN)

182.50 0.00 (0.00%)
Closed USD Disclaimer

ALXN Financial Summary

For the three months ended 31 March 2021, AlexionPharmaceuticals, Inc. revenues increased 13% to $1.64B. Netincome increased 14% to $636M. Revenues reflect ULTOMIRISsegment increase of 56% to $346.9M, Strensiq segmentincrease of 15% to $197.5M. Net income benefited fromAcquisition-related costs decrease of 65% to $13.2M(expense), Amortization of purchased intangible assdecrease of 28% to $53.2M (expense).
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
ALXN
Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
Total Revenue
Net Income
Title
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Total Revenue 1,636.50 1,591.80 1,588.70 1,444.60
Gross Profit 1,511.10 1,439.60 1,444 1,299.70
Operating Income 636.20 622.10 684.90 -1,370.20
Net Income 636 535.80 578.10 -1,068.10
Clear All
0Selected
Please try another search
ALXN
Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets
Total Liabilities
Title
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Total Assets 18,650.20 18,103 17,548.40 16,703.20
Total Liabilities 6,233.40 6,451.80 6,473.50 6,212.40
Total Equity 12,416.80 11,651.20 11,074.90 10,490.80
Clear All
0Selected
Please try another search
ALXN
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow 44.71%
Cash
Net Change in Cash
Title
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Cash From Operating Activities 637.60 3,002.90 2,162.40 1,339.60
Cash From Investing Activities -133.90 -2,099.50 -2,018.90 -751.50
Cash From Financing Activities -18.70 -611.90 -538.10 -430.70
Net Change in Cash 471.90 311 -395.10 149.30
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.